Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ORIC-114
i
Other names:
ORIC-114, VRN07
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
ORIC Pharma, Voronoi
Drug class:
EGFR inhibitor, HER2 inhibitor
Related drugs:
‹
cetuximab (317)
osimertinib (240)
erlotinib (229)
afatinib (217)
gefitinib (183)
panitumumab (114)
lapatinib (105)
neratinib (102)
pyrotinib (64)
brigatinib (45)
icotinib (39)
aumolertinib (22)
amivantamab-vmjw (15)
BGB-283 (12)
furmonertinib (11)
lazertinib (9)
mobocertinib (7)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
ASLAN001 (6)
CL-387785 (5)
nimotuzumab (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BDTX-1535 (4)
BI-4020 (4)
BLU-945 (4)
tomuzotuximab (4)
GB263T (4)
JIN-A02 (4)
TAS2940 (4)
EGF816 (4)
BBT-176 (3)
BLU-701 (3)
GC-1118A (3)
ASP8273 (3)
DZD9008 (3)
BCA101 (2)
BI-732 (2)
Bay846 (2)
MCLA-129 (2)
OBX02-011 (2)
olmutinib (2)
necitumumab (2)
QL1203 (2)
S95026 (2)
CLN-081 (2)
14aj (1)
ABN202 (1)
ABP 494 (cetuximab biosimilar) (1)
AFM24 (1)
APL-103 (1)
BLU-451 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
befotertinib (1)
TAS3351 (1)
S-222611 (1)
HMPL-813 (1)
ASK120067 (1)
MET306 (1)
SH-1028 (1)
HLX07 (1)
KD019 (1)
AZD3759 (1)
trastuzumab (369)
tucatinib (32)
trastuzumab-pkrb (23)
margetuximab (18)
poziotinib (16)
MCLA-128 (15)
KN026 (12)
trastuzumab-dttb (11)
ZW25 (10)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
Zercepac (trastuzumab biosimilar) (7)
trastuzumab-IFN-β mutein (3)
inetetamab (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
pertuzumab/trastuzumab/hyaluronidase-zzxf (2)
AB-201 (1)
ABL105 (1)
ACE1702 (1)
AST-301 (1)
Hercease (trastuzumab biosimilar) (1)
CT-0508 (1)
EG12014 (trastuzumab biosimilar) (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
IMM2902 (1)
MP0274 (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
cetuximab (317)
osimertinib (240)
erlotinib (229)
afatinib (217)
gefitinib (183)
panitumumab (114)
lapatinib (105)
neratinib (102)
pyrotinib (64)
brigatinib (45)
icotinib (39)
aumolertinib (22)
amivantamab-vmjw (15)
BGB-283 (12)
furmonertinib (11)
lazertinib (9)
mobocertinib (7)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
ASLAN001 (6)
CL-387785 (5)
nimotuzumab (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BDTX-1535 (4)
BI-4020 (4)
BLU-945 (4)
tomuzotuximab (4)
GB263T (4)
JIN-A02 (4)
TAS2940 (4)
EGF816 (4)
BBT-176 (3)
BLU-701 (3)
GC-1118A (3)
ASP8273 (3)
DZD9008 (3)
BCA101 (2)
BI-732 (2)
Bay846 (2)
MCLA-129 (2)
OBX02-011 (2)
olmutinib (2)
necitumumab (2)
QL1203 (2)
S95026 (2)
CLN-081 (2)
14aj (1)
ABN202 (1)
ABP 494 (cetuximab biosimilar) (1)
AFM24 (1)
APL-103 (1)
BLU-451 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
befotertinib (1)
TAS3351 (1)
S-222611 (1)
HMPL-813 (1)
ASK120067 (1)
MET306 (1)
SH-1028 (1)
HLX07 (1)
KD019 (1)
AZD3759 (1)
trastuzumab (369)
tucatinib (32)
trastuzumab-pkrb (23)
margetuximab (18)
poziotinib (16)
MCLA-128 (15)
KN026 (12)
trastuzumab-dttb (11)
ZW25 (10)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
Zercepac (trastuzumab biosimilar) (7)
trastuzumab-IFN-β mutein (3)
inetetamab (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
pertuzumab/trastuzumab/hyaluronidase-zzxf (2)
AB-201 (1)
ABL105 (1)
ACE1702 (1)
AST-301 (1)
Hercease (trastuzumab biosimilar) (1)
CT-0508 (1)
EG12014 (trastuzumab biosimilar) (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
IMM2902 (1)
MP0274 (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
EGFR H773_V774insH
Non Small Cell Lung Cancer
EGFR H773_V774insH
Non Small Cell Lung Cancer
ORIC-114
Sensitive: D – Preclinical
ORIC-114
Sensitive
:
D
ORIC-114
Sensitive: D – Preclinical
ORIC-114
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login